Itsuro Nagase

Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function

Toshiyuki Takasu, Masashi Ukai, Shuichi Sato et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 307 citations

Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist.

Itsuro Nagase, Takeshi Yoshida, Kenzo Kumamoto et al. · Journal of Clinical Investigation · 1996 · 206 citations · Full text

Mitochondrial Uncoupling Protein, Obesity, Metabolic Syndrome +20

Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus

Atsunori Kashiwagi, Kenichi Kazuta, Satoshi Yoshida et al. · Journal of Diabetes Investigation · 2013 · 98 citations · Full text

Ipragliflozin improves glycemic control in Japanese patients with type 2 diabetes mellitus: the BRIGHTEN study

Atsunori Kashiwagi, Kenichi Kazuta, Yuusuke Takinami et al. · Diabetology International · 2014 · 81 citations

Obesity, Metabolic Syndrome, Diabetes Management +5

Up‐regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator‐activated receptor ligands and 9‐<i>cis</i> retinoic acid in L6 myotubes

Itsuro Nagase, Shigeru Yoshida, Xavier Cañas et al. · FEBS Letters · 1999 · 73 citations